
Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute | ![]() |
|---|---|
| Category | Muscle |
| Evidence grade | C Preclinical research |
| Regulatory status | Not approved — research use only |
| Human amounts | None establishedDosing reference Study durations |
| Format | Lyophilized vial |
| Type | Single compound |
| Molecular formula | Not listed |
| Molecular weight | Not listed |
| CAS number | Not listed |
| Sequence | N- |
| References | 9 |
| Summary | IGF-1 LR3 (Long R3 IGF-I) is a recombinant analogue of human insulin-like growth factor I with an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, designed as a laboratory reagent that binds poorly to IGF-binding proteins. It has been studied in cell culture and animals, but no published human administration study was identified. It is not approved for human use, is distinct from the FDA-approved drug mecasermin, and is prohibited in sport; this entry is for research reference only. |
